APA Webinar: Medication Assisted Treatment of Opioid Use Disorders: Progress and Challenges
January 8, 2016
Tuesday, January 12, 2016, 12:00 – 1:00 pm ET
Webinar Description: For decades, medication assisted treatment for opioid use disorders has shown enormous potential for saving lives. When prescribed and monitored properly, medications such as methadone, buprenorphine, and naltrexone are safe and cost-effective components of opioid use disorder treatment that can improve lives, reduce the risk of overdose, increase patient retention, and decrease drug use, infectious disease transmission, and criminal activity. Despite their potential for positive outcomes, however, medication-assisted therapies are still markedly underutilized for a variety of reasons including inadequate provider education and misunderstandings about addiction medications by the public, healthcare providers, insurers, and patients. One common, long-held, stigma-generating misperception, for example, is that medication-assisted therapies merely replace one substance use disorder for another.
The skyrocketing abuse of both prescription opioids and heroin in recent years dramatically amplifies the urgency for increased access to and improved utilization of these valuable treatment strategies.
Presenter: Nora D. Volkow, MD | Director, National Institute on Drug Abuse